Aug 2026· Frontiers in Medicine· Vol 13· 0 citations· 36 references
Medicine
TL;DR
The XGBoost-based ML model showed potential for predicting 30-day readmission after hip surgery and may provide supportive information for perioperative risk stratification and modifiable management strategies, particularly nutritional optimization and temperature management.
Abstract
Objective To develop and internally validate a machine learning (ML)-based model for predicting 30-day postoperative readmission after hip surgery using multidimensional perioperative data, and to evaluate its potential clinical utility. Methods This single-center retrospective cohort study included 720 patients who underwent hip-related surgery at Guangxi Zhuang Autonomous Region People’s Hospital between 2022 and 2025. Patients were randomly divided into training and test sets at a 7:3 ratio. Demographic characteristics, comorbidities, laboratory variables, anesthesia and temperature-management variables, surgical characteristics, and transfusion-related variables were extracted. Candidate predictors were first selected in the training set using the Boruta algorithm. Eleven base models and one stacking ensemble model were then developed using the selected features. Hyperparameters were optimized using 5-fold cross-validation combined with grid search. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) and the area under the precision-recall curve (PRAUC), while decision curve analysis (DCA) and SHapley Additive exPlanations (SHAP) were used to assess clinical net benefit and model interpretability. Results The overall 30-day readmission rate was 4.3%. In the test set, the XGBoost model achieved an AUC of 0.88 and a PRAUC of 0.53. Across commonly used threshold probabilities, XGBoost provided a higher net benefit than treat-all or treat-none strategies. SHAP analysis identified preoperative albumin, post-anesthesia care unit (PACU) temperature, warming duration, age, and heart failure as the leading predictors of readmission risk. Conclusion The XGBoost-based ML model showed potential for predicting 30-day readmission after hip surgery and may provide supportive information for perioperative risk stratification and modifiable management strategies, particularly nutritional optimization and temperature management.
LightGBM shows the best overall performance for risk stratification of PONV after craniotomy, and SHAP visualization endows the model with favorable clinical interpretability to facilitate individualized risk prediction.
Ling-Yi Wu, Hong-Ying Pan, Yi-Hong Xu et al.· Frontiers in Medicine· 0 citations
Logistic regression demonstrated the best overall discriminative ability, calibration, clinical net benefit, and cross-cohort generalizability, and is recommended as the preferred tool for individualized risk assessment.
Li-Ling Pan, Li-Zhi He, Jian-Zhen Zhao et al.· Frontiers in Surgery· 0 citations
The LGBM model constructed based on the MIMIC-IV database has excellent predictive efficacy for VTE after orthopedic surgery and certain external generalization abilities, providing a reference for the early identification of high-risk individuals in clinical settings.
Gen-Fa Wu, Geng-Jiao Cai, Gang Wu et al.· Frontiers in Surgery· 0 citations
The XGBoost model developed in this study achieved a relatively high AUC of 0.901, indicating that the model’s ability to confirm prolonged PACU stay remains somewhat insufficient, and can be used as an auxiliary screening tool in clinical rather than a definitive diagnostic tool.
Na Zhu, Xiang Xiong, Xuan-Zhao Wu et al.· BMC Anesthesiology· 0 citations
Findings indicate that gradient boosting models based on routinely collected clinical variables can provide interpretable and clinically useful predictions to support individualized rehabilitation planning and discharge management after lower-limb arthroplasty.
M. Morri, Monica Guberti, L. Verzellesi et al.· Applied Sciences· 0 citations
Logistic Regression showed potential as an interpretable early ICU risk-stratification tool and externally validated machine learning models for in-hospital mortality prediction in patients with diabetes and ARDS.
Ya-Lin Dong, Meng-Xue Hou, Qian-Qian Wang et al.· Shock· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.